x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Molecule to Market: Inside the outsourcing space

Molecule to Market takes you inside the global pharma and biopharma outsourcing ecosystem. Each week, our host Raman Sehgal sits down with the founders, entrepreneurs, CEOs and C-suite leaders shaping the pharma services and tools that power discovery, drug development and commercialization. Listeners get real stories and practical insights from across the entire value chain, from big pharma and emerging biotechs to private equity investors, CROs, CDMOs, technology platforms and specialist

science life sciences

All Episodes

32:10

2021 mid-year CDMO Review: COVID-19 Vaccine...

Molecule to Market: Inside the outsourcing space ·

2021/06/23

In today’s special ‘bite-sized’ Molecule to Market episode, I’ll be talking with Jim Miller about the CDMO space at the half point mark in 2012. Inspired by this terrific article https://www.dcatvci.org/7173-mid-year-cdmo-review-covid-19-vaccine-manufacturing-and-m-a on the DCAT ValueChain Insights websites, Jim covers: Vaccine manufacturing, capacity constraints and the increasing scale and role of the CDMO in the pharma space. 32+ M&A deals already and an outlook for more (and bigger) activity on

en

46:19

The unique general

Molecule to Market: Inside the outsourcing space ·

2021/05/20

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Andrew Moore, General Manager at Pfizer CentreOne. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Andrew, covering: The pride of being part of Pfizer in the last year and first-hand experience of working with CEO Albert Bourla. Lifelong leadership lessons learnt during eight years of military service in Iraq, where decisions cost

en

35:58

The Stickability factor

Molecule to Market: Inside the outsourcing space ·

2021/05/12

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Tom Moody, Vice President of Technology Development and Commercialisation at Almac. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Tom, covering: 20 years at Almac and being on a journey that has seen the company go from a few hundred staff to over 5500 people. The chemistry of today is not the chemistry of tomorrow, including the future

en

50:08

Poacher turned gamekeeper, turned hybrid

Molecule to Market: Inside the outsourcing space ·

2021/04/30

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Peter Bigelow President at xCell Strategic Consulting. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Peter, covering: The transition from being on the big pharma sponsor side at Pfizer to being head of one of the world’s biggest CDMOs. The challenging of adding a development capability to well-oiled manufacturing infrastructure and way

en

58:46

The humble leader

Molecule to Market: Inside the outsourcing space ·

2021/04/21

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Steve Ferguson, Chief Executive Officer at Medix Biochemica. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Steve, covering: The positive and negative impact of Covid-19 on the diagnostic sector. And the need for more spend on diagnostic sector moving forward. How his humble and grounded upbringing gave him an early respect for the

en

36:22

The understated, elite vaccine scientist

Molecule to Market: Inside the outsourcing space ·

2021/04/14

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Archie Lovatt Life Sciences Biosafety Scientific Director at SGS. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Archie, covering: Being motivated by saving lives and seeing your contribution make a real impact on the world. Following your heart and not chasing the money. Seeing Covid-19 drugs developed in a parallel rather than

en

42:57

Creating a healthy culture

Molecule to Market: Inside the outsourcing space ·

2021/04/01

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jeff Dill, CEO at Vynamic. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Jeff, covering:· How to create, document, grow and internationally scale an incredible business culture. The shift towards greater industry collaboration as an important step for quicker drug approvals in the future. Servant leadership philosophy - to listen, be

en

44:22

40 at 40

Molecule to Market: Inside the outsourcing space ·

2021/03/25

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Raman Sehgal Founder & Global President of ramarketing & usual host of the Molecule to Market podcast. Raman has 20+ years of marketing and life science industry experience. Starting his career and setting up his business in the UK, Raman now resides stateside after relocating to the US to open an office in Boston. Raman previously worked for The Specials Laboratory and SCM

en

35:05

From Pfizer to CDMO start-up

Molecule to Market: Inside the outsourcing space ·

2021/03/17

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Gerry Cox, Founder and Chief Operating Officer at Velesco Pharmaceutical Services. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Gerry, covering: The transition from two decades in Big Pharma to the entrepreneurial world of running a CDMO. Becoming known as the ‘lab down the hall’ for many clients with products in the clinical phase

en

45:02

Expanding drug dosage possibilities…

Molecule to Market: Inside the outsourcing space ·

2021/03/10

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Megan Greth, Director of Marketing & Business Development and Tadgh Prendeville, General Manager at ARx LLC. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Megan and Tadgh, covering: The developments & demands for new transdermal drug products and oral thin films as a more patient centric drug delivery platform. How the focus on

en

38:32

From Teesside Uni to global leader

Molecule to Market: Inside the outsourcing space ·

2021/03/03

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jarlath Keating President & CEO at ABL Inc. Jarlath has over 25 years of global life science industry experience. Starting his career in the UK in the early 90’s before transitioning to the US in 2009. During this time, Jarlath worked for HyClone and Lonza Biologics. He served as the Vice President of Global Commercial Operations for MilliporeSigma’s Process Solutions Services

en

36:44

The accidental CDMO

Molecule to Market: Inside the outsourcing space ·

2021/02/22

In this episode of Molecule to Market, your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with guest Richard Johnson, Founding Director of Upperton Pharma Solutions. With more than 25 years of experience in the industry, Richard is a founding director of two, successful pharmaceutical companies. He has authored 30 scientific publications and is the named-inventor on more than 20 patents. His research experience spans a broad range of scientific disciplines

en

41:37

The passionate problem solver

Molecule to Market: Inside the outsourcing space ·

2021/02/15

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Robert Lee Ph.D., President at the CDMO Division of Lubrizol Life Science Health (LLS). Rob has over 30 years’ experience in the pharmaceutical R&D space and his areas of expertise include drug delivery, formulation development, analytical sciences and sterile manufacturing. With a Ph.D. in Physical Bioorganic Chemistry, Rob has published more than three dozen articles and five

en

39:10

The entrepreneurial scientist

Molecule to Market: Inside the outsourcing space ·

2021/02/08

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Alok Tayi, Vice President of Life Sciences at Egnyte and the founder of the Biotech 2050 podcast. Alok has a very impressive academic and entrepreneurial background in life sciences, before running the fast-growing life science division at Egnyte, he was a Co-Founder of PreScouter and TetraScience, raising millions along the way. Having completed a postdoctoral fellowship at

en

48:43

The sales guru

Molecule to Market: Inside the outsourcing space ·

2021/01/28

In this episode of Molecule to Market, we do things a little differently with an experimental episode. You’ll go inside the outsourcing space of the global drug development sector with the best-selling sales author, Ian Altman. Ian started, sold, and grew his prior companies from zero to over one billion dollars in value. He’s a co-author of the bestseller, Same Side Selling, now in its second edition. He is the author of hundreds of articles on Forbes and Inc. Ian is recognized as one of the

en

52:02

Marathons. Wine. And 30 years in healthcare.

Molecule to Market: Inside the outsourcing space ·

2021/01/21

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Marco Chiado’ Piat, President, at Terumo Pharmaceutical Solutions part of Terumo. Marco has worked in the pharma and healthcare sector since the early 1990s. His impressive experience has included eight years at McKinsey before he founded a VC business. He then had several senior roles at medical device specialist LivaNova before joining Terumo Pharmaceutical Solutions in 2017,

en

51:55

The industry guru

Molecule to Market: Inside the outsourcing space ·

2021/01/14

In this one hour special episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jim Miller. If you’ve worked in the bio and pharmaceutical CDMO space for a few years, then there’s a very good chance you will know my guest today. Jim is a renowned expert in the space and a regular speaker at all the major trade conferences including CPhI WW. He made his name in the sector after founding and growing PharmSource with his wife Judy, an online

en

21:20

10 Trends for 2021

Molecule to Market: Inside the outsourcing space ·

2021/01/08

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with... Raman Sehgal, founder of ramarketing and the Molecule to Market podcast. Your host, Raman shares ten trends that he expects to see in 2021 and beyond based on themes from podcast interviews and expert insights gathered in 2020. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing

en

51:46

The CDMO Disrupter

Molecule to Market: Inside the outsourcing space ·

2020/12/10

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Tia Lyles-Williams, CEO of LucasPye Bio. Tia is the first African-American Queer Woman to own & lead a Biopharma Large-Scale Manufacturing Company in the US. She has spent 20 years in the industry formerly working for the U.S. Federal Government, Big Pharma and Small Biotech Companies, before setting up her own CDMO. Tia is not only highly knowledgeable about the biotechnology

en

48:56

The biologic CDMO growth guy

Molecule to Market: Inside the outsourcing space ·

2020/11/24

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Roger Lias, Chief Executive Officer at Stelis Biopharma. A fellow-Brit, Roger is a graduate of the University of Southampton. He also holds a PhD in Biotechnology from the University of Cambridge. His experience of the biopharma CDMO space in particular spans over 30 years including roles with the likes of Lonza, Diosynth, KBI Biopharma, Cytovance Biologics, Eden Biodesign,

en

248 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter